Birchview Capital, LP Biodesix Inc Transaction History
Birchview Capital, LP
- $116 Million
- Q1 2024
A detailed history of Birchview Capital, LP transactions in Biodesix Inc stock. As of the latest transaction made, Birchview Capital, LP holds 5,193,336 shares of BDSX stock, worth $7.95 Million. This represents 6.38% of its overall portfolio holdings.
Number of Shares
5,193,336
Previous 5,193,336
-0.0%
Holding current value
$7.95 Million
Previous $8.57 Million
13.34%
% of portfolio
6.38%
Previous 7.6%
Shares
7 transactions
Others Institutions Holding BDSX
# of Institutions
45Shares Held
16.2MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD3.32MShares$5.08 Million1.91% of portfolio
-
Telemark Asset Management, LLC Boston, MA1.33MShares$2.03 Million0.22% of portfolio
-
Essex Investment Management CO LLC Boston, MA926KShares$1.42 Million0.27% of portfolio
-
Wells Fargo & Company San Francisco, CA893KShares$1.37 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA808KShares$1.24 Million0.0% of portfolio
About BIODESIX INC
- Ticker BDSX
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 39,982,000
- Market Cap $61.2M
- Description
- Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...